Intravenous (IV) solution Market 2024 | Analysis by Industry Trends, Size, Share, Company Overview, Growth, Development and Forecast by 2032

The global Intravenous (IV) solution market was valued at USD 8.0 billion in 2022 and is projected to grow rapidly, registering a compound annual growth rate (CAGR) of 8.5% over the forecast period. Key factors driving this growth include the rising prevalence of immunodeficiency diseases, an increasing geriatric population, and ongoing technological advancements in medical therapies.

Key Drivers of Market Growth

The IV solution market is benefiting from several important trends. One of the most significant is the introduction of smart IV pumps, which enhance patient safety by automatically adjusting infusion rates based on individual patient needs. These pumps help minimize medication errors and improve overall care.

Technological advancements continue to drive the market, with innovations like nanoparticle-based IV solutions, closed-loop systems, and wireless IV pumps leading to more personalized and effective treatments. As these technologies become more widely available, they are expected to play a crucial role in improving patient outcomes.

You Can Download Free Sample PDF Copy Of This Report @ https://www.emergenresearch.com/request-sample/2719

The increasing prevalence of cancer and neurological disorders is another major contributor to market growth. According to the World Health Organization (WHO), cancer was responsible for 10 million deaths in 2020, making it the leading cause of death worldwide. Similarly, neurological disorders, such as strokes and Alzheimer's disease, account for around 9 million deaths each year. These conditions often require IV therapy to manage symptoms and improve patients' quality of life.

An aging global population also presents a significant market opportunity. Older adults are more susceptible to chronic conditions like heart failure, diabetes, and kidney disease, which frequently require IV treatment to address dehydration, electrolyte imbalances, and nutritional deficiencies. The demand for IV therapy is further boosted by the increasing availability of home infusion services, allowing patients to receive treatment in the comfort of their homes.

Segment Insights: TPN and PPN

The IV solution market is segmented into Total Parenteral Nutrition (TPN) and Peripheral Parenteral Nutrition (PPN). In 2022, TPN accounted for the largest share of the market due to the growing prevalence of ulcerative colitis and advancements in parenteral nutrition formulations. TPN solutions are becoming more effective and easier to administer, making them a preferred choice for long-term nutritional support. The shift toward home-based healthcare has also increased demand for TPN solutions.

Meanwhile, the PPN segment is expected to see steady growth as minimally invasive surgeries become more common. PPN is often used during recovery from procedures like laparoscopic surgery and endoscopy, providing essential nutritional support. Advances in PPN formulations and delivery systems, such as portable pumps and more concentrated solutions, are making this therapy more convenient for both patients and healthcare providers.

Nutritional Solutions Driving Growth

In terms of nutrition, the amino acid solution segment is expected to lead the market, driven by the rising prevalence of chronic liver diseases like cirrhosis. Amino acid solutions are commonly used to treat these conditions, which affect millions of people worldwide. New formulations, such as those approved by the U.S. Food and Drug Administration (FDA), allow for higher protein content in IV solutions, improving the effectiveness of treatment.

The vitamin and mineral segment is also expected to grow steadily, thanks to the increasing incidence of anemia and other deficiencies. The World Health Organization (WHO) estimates that anemia affects about 25% of the global population, particularly children, pregnant women, and women of reproductive age. As awareness of the importance of vitamins and minerals in maintaining health grows, the demand for IV solutions providing these nutrients is rising.

Hospital Segment Leads in End Users

The hospital segment is anticipated to dominate the market during the forecast period. Hospitals are the primary point of care for patients requiring IV therapy, especially for critical care, liver cirrhosis, and anemia. Many patients prefer receiving IV treatment in hospitals due to the availability of advanced medical facilities and the expertise required to administer these therapies safely.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/intravenous-solution-market

Minimally invasive procedures, such as laparoscopic surgeries, are also increasingly performed in hospitals, further driving demand for IV solutions to ensure hydration and nutrition during recovery.

Challenges Facing the Market

Despite the positive growth outlook, the high cost of IV therapy remains a significant challenge, particularly in low- and middle-income countries where access to affordable healthcare is limited. Rising costs place a financial burden on patients and healthcare systems, potentially limiting the widespread adoption of IV therapies.

However, with continued technological advancements and the increasing prevalence of chronic diseases, the IV solution market is expected to remain strong, providing essential support to millions of patients worldwide.

IV Solution Top Companies and Competitive Landscape

The global IV solution market is fairly fragmented, with many large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing a more effective IV solution products.

Some major players included in the global IV solution market report are:

Baxter International Inc.
Ajinomoto Co., Inc.
Braun Group
Pfizer
Grifols
FRESENIUS KABI
CSL Vifor
ICU Medical
Terumo Medical Corporation
Otsuka

IV Solution Latest Industry Updates

On 5 December 2022, Liquidia Corporation announced its partnership with Sandoz and Mainbridge Health to develop a new subcutaneous pump for administering Treprostinil Injection, a generic form of Remodulin. Treprostinil Injection is the first and only fully substitutable generic Treprostinil for parenteral administration. This generic form is offered to patients and physicians with the same level of service and support, but at a lower price than the branded drug.

On 4 May 2022, Fresenius Kabi announced to acquire Ivenix, Inc. to expand its infusion therapy offerings in the U.S. Ivenix's cutting-edge infusion therapy platform complements Fresenius Kabi's existing portfolio, providing advanced hospital connectivity and interoperability solutions. This strategic move strengthens Fresenius Kabi's position in the infusion therapy market, offering a wider range of premium products to healthcare providers. The combination of Ivenix's hardware and software expertise with Fresenius Kabi's IV fluids and infusion devices creates a comprehensive and leading solution in the industry
IV Solution Market Segmentation Analysis

For the purpose of this report, Emergen Research has segmented the global IV solution market on the basis of type, application, end-use, and region:

Type Outlook (Revenue, USD Billion; 2019-2032)

Total Parenteral Nutrition
Peripheral Parenteral Nutrition

Nutrition Outlook (Revenue, USD Billion; 2019-2032)

Amino Acid Solution
Vitamin and Minerals
Carbohydrates
Others

End-Use Outlook (Revenue, USD Billion; 2019-2032)

Hospitals
Clinics
Homecare

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2719

Regional Outlook (Revenue, USD Billion; 2019-2032)

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of Middle East & Africa

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.